Currently, the CDC maintains no Level 4 Travel Health Notices, the highest tier reserved for destinations with extreme health risks where no effective precautions exist. Recent outbreaks, including a May 2026 multi-country hantavirus cluster linked to cruise travel, prompted only a Level 3 emergency operations activation with limited public risk, while suspected Ebola cases in the DRC triggered entry restrictions but no Level 4 classification. Official surveillance data through mid-2026 show no novel pathogen meeting the criteria of widespread, unpreventable severe threat across regions. Traders assign 75% probability to “No” because baseline epidemiological indicators and agency monitoring thresholds have not shifted toward escalation in the six months remaining.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoCDC issues Level 4 warning by December 31?
CDC issues Level 4 warning by December 31?
$71,871 Wol.
$71,871 Wol.
Dec 31, 2026
$71,871 Wol.
$71,871 Wol.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Currently, the CDC maintains no Level 4 Travel Health Notices, the highest tier reserved for destinations with extreme health risks where no effective precautions exist. Recent outbreaks, including a May 2026 multi-country hantavirus cluster linked to cruise travel, prompted only a Level 3 emergency operations activation with limited public risk, while suspected Ebola cases in the DRC triggered entry restrictions but no Level 4 classification. Official surveillance data through mid-2026 show no novel pathogen meeting the criteria of widespread, unpreventable severe threat across regions. Traders assign 75% probability to “No” because baseline epidemiological indicators and agency monitoring thresholds have not shifted toward escalation in the six months remaining.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Rynek otwarty: Jan 19, 2026, 3:15 PM ET
Wolumen
$71,871Data zakończenia
Dec 31, 2026Rynek otwarty
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Currently, the CDC maintains no Level 4 Travel Health Notices, the highest tier reserved for destinations with extreme health risks where no effective precautions exist. Recent outbreaks, including a May 2026 multi-country hantavirus cluster linked to cruise travel, prompted only a Level 3 emergency operations activation with limited public risk, while suspected Ebola cases in the DRC triggered entry restrictions but no Level 4 classification. Official surveillance data through mid-2026 show no novel pathogen meeting the criteria of widespread, unpreventable severe threat across regions. Traders assign 75% probability to “No” because baseline epidemiological indicators and agency monitoring thresholds have not shifted toward escalation in the six months remaining.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Wolumen
$71,871Data zakończenia
Dec 31, 2026Rynek otwarty
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Currently, the CDC maintains no Level 4 Travel Health Notices, the highest tier reserved for destinations with extreme health risks where no effective precautions exist. Recent outbreaks, including a May 2026 multi-country hantavirus cluster linked to cruise travel, prompted only a Level 3 emergency operations activation with limited public risk, while suspected Ebola cases in the DRC triggered entry restrictions but no Level 4 classification. Official surveillance data through mid-2026 show no novel pathogen meeting the criteria of widespread, unpreventable severe threat across regions. Traders assign 75% probability to “No” because baseline epidemiological indicators and agency monitoring thresholds have not shifted toward escalation in the six months remaining.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania